169 related articles for article (PubMed ID: 16076703)
21. Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the dunning R-3327 rat prostatic adenocarcinoma system as a model.
Lowe FC; Isaacs JT
Cancer Res; 1984 Feb; 44(2):744-52. PubMed ID: 6537899
[TBL] [Abstract][Full Text] [Related]
22. HMGA2 expression in a canine model of prostate cancer.
Winkler S; Murua Escobar H; Meyer B; Simon D; Eberle N; Baumgartner W; Loeschke S; Nolte I; Bullerdiek J
Cancer Genet Cytogenet; 2007 Sep; 177(2):98-102. PubMed ID: 17854662
[TBL] [Abstract][Full Text] [Related]
23. [Expression and significance of gonadotropin-releasing hormone receptor in the endometrium of normal and endometrial cancer uterus].
Yue Y; Piao JX; Wang LN; Pu JW; Gao FD
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):326-8. PubMed ID: 16762189
[TBL] [Abstract][Full Text] [Related]
24. Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model.
Mohler JL; Partin AW; Isaacs JT; Coffey DS
Cancer Res; 1988 Aug; 48(15):4312-7. PubMed ID: 3390827
[TBL] [Abstract][Full Text] [Related]
25. Expression of gonadotropin-releasing hormone receptor in cerebral cortical neurons of embryos and adult rats.
Quintanar JL; Salinas E; González R
Neurosci Lett; 2007 Jan; 411(1):22-5. PubMed ID: 17110036
[TBL] [Abstract][Full Text] [Related]
26. Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression.
Wilson AC; Salamat MS; Haasl RJ; Roche KM; Karande A; Meethal SV; Terasawa E; Bowen RL; Atwood CS
J Endocrinol; 2006 Dec; 191(3):651-63. PubMed ID: 17170222
[TBL] [Abstract][Full Text] [Related]
27. Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis.
Bussemakers MJ; van de Ven WJ; Debruyne FM; Schalken JA
Cancer Res; 1991 Jan; 51(2):606-11. PubMed ID: 1702360
[TBL] [Abstract][Full Text] [Related]
28. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA
Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
[TBL] [Abstract][Full Text] [Related]
30. Gonadotropin-releasing hormone receptor in spinal cord neurons of embryos and adult rats.
Quintanar JL; Salinas E; González R
Neurosci Lett; 2009 Sep; 461(1):21-4. PubMed ID: 19539704
[TBL] [Abstract][Full Text] [Related]
31. Rapid suppression of plasma testosterone levels and tumor growth in the dunning rat model treated with degarelix, a new gonadotropin-releasing hormone antagonist.
Princivalle M; Broqua P; White R; Meyer J; Mayer G; Elliott L; Bjarnason K; Haigh R; Yea C
J Pharmacol Exp Ther; 2007 Mar; 320(3):1113-8. PubMed ID: 17179469
[TBL] [Abstract][Full Text] [Related]
32. Proliferation of TSU-Pr1, a human prostatic carcinoma cell line is stimulated by gonadotropin-releasing hormone.
Enomoto M; Seong JY; Kawashima S; Park MK
Life Sci; 2004 May; 74(25):3141-52. PubMed ID: 15081579
[TBL] [Abstract][Full Text] [Related]
33. CCR2 expression correlates with prostate cancer progression.
Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
[TBL] [Abstract][Full Text] [Related]
34. Molecular cloning and gene expression of the gonadotropin-releasing hormone receptor in the orange-spotted grouper, Epinephelus coioides.
Hsieh SL; Chuang HC; Nan FH; Ruan YH; Kuo CM
Comp Biochem Physiol B Biochem Mol Biol; 2007 Jun; 147(2):209-21. PubMed ID: 17329139
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional regulation of human protease-activated receptor 1: a role for the early growth response-1 protein in prostate cancer.
Salah Z; Maoz M; Pizov G; Bar-Shavit R
Cancer Res; 2007 Oct; 67(20):9835-43. PubMed ID: 17942914
[TBL] [Abstract][Full Text] [Related]
36. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
Vaday GG; Peehl DM; Kadam PA; Lawrence DM
Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154
[TBL] [Abstract][Full Text] [Related]
37. Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma.
Epner DE; Partin AW; Schalken JA; Isaacs JT; Coffey DS
Cancer Res; 1993 May; 53(9):1995-7. PubMed ID: 8481901
[TBL] [Abstract][Full Text] [Related]
38. Effects of GABA(A) receptor modulation on the expression of GnRH gene and GnRH receptor (GnRH-R) gene in the hypothalamus and GnRH-R gene in the anterior pituitary gland of follicular-phase ewes.
Ciechanowska M; Lapot M; Malewski T; Mateusiak K; Misztal T; Przekop F
Anim Reprod Sci; 2009 Apr; 111(2-4):235-48. PubMed ID: 18434046
[TBL] [Abstract][Full Text] [Related]
39. The effect of stress on the expression of GnRH and GnRH receptor genes in the discrete regions of the hypothalamus and pituitary of anestrous ewes.
Łapot M; Ciechanowska M; Malewski T; Misztal T; Mateusiak K; Przekop F
Reprod Biol; 2007 Mar; 7(1):55-71. PubMed ID: 17435833
[TBL] [Abstract][Full Text] [Related]
40. Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
Peternac D; Klima I; Cecchini MG; Schwaninger R; Studer UE; Thalmann GN
Prostate; 2008 Sep; 68(12):1307-18. PubMed ID: 18512728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
